Published 22:32 IST, November 23rd 2020
Rahul Gandhi poses 4 questions to PM on COVID Vaccine strategy, brings in ‘PM-CARES’
As several states in India witnesses a spike in Coronavirus, ex-Congress chief Rahul Gandhi on Monday, posed four questions to Centre on vaccine distribution
- India News
- 3 min read
As several states in India witnesses a spike in Coronavirus (COVID-19), ex-Congress chief Rahul Gandhi on Monday, posed four questions to the Centre regarding vaccine distribution. He asked the Centre which vaccine will be chosen and why, who will get the vaccine first, when will all Indians be vaccinated and will PM-CARES fund will be used to ensure free vaccination. India's total COVID-19 cases are at 91,39,866 with 1,33,738 fatalities.
Rahul Gandhi: 'Which vaccine will be chosen?'
India mulls emergency usage of AstraZeneca-Oxford vaccine
In a heartening development, Oxford University has announced, earlier in the day, that its COVID-19 vaccine candidate developed in collaboration with AstraZeneca is 70.4% effective against the highly-infectious disease. Announcing the interim trial data from its Phase 3 trials, Oxford University said in a statement that its vaccine candidate ChAdOx1 nCoV-2019 has shown more than 70 per cent efficacy after the analysis included 131 COVID-19 cases. India is mulling to approve the Oxford-AstraZeneca vaccine for emergency use, once the UK government clears it.
Apart from Oxford's 'COVISHIELD', four other COVID-19 vaccine candidates are currently in various human trial phases in India -Bharat Biotech - ICMR (BBV 152), Cadila-Zydus (ZyCOV-D), Serum-ICMR & Novavax and Russia- Dr.Reddy's (Sputnik V). The Central Drugs Standard Control Organisation (CDSCO) has listed 7 Indian manufacturers permitted for COVID-19 vaccine manufacturing - Serum Institute of India (SII), Cadila Healthcare, Bharat Biotech, Biological E, Reliance Life Sciences, Aurbindo Pharma, and Gennova Biopharmaceuticals. Recently, the Centre allotted Rs. 900 crore for research related to COVID-19 vaccine development excluding the cost of vaccine or logistics for vaccine distribution.
Curfews in parts of India
While Delhi has ruled out a lockdown, it has increased the fine on not wearing masks to Rs 2000. Gujarat has introduced a 3-day lockdown in Ahmedabad, nightly curfews in Rajkot, Surat, and Vadodara from November 21. Similarly, Madhya Pradesh has introduced night curfew in Bhopal, Indore, Gwalior, Ratlam and Vidisha districts with effect from November 21. Rajasthan too has decided to impose a night curfew in 8 districts - Jaipur, Jodhpur, Kota, Bikaner, Udaipur, Ajmer, Alwar, and Bhilwara and increased the fine amount on not wearing a face mask from Rs 200 to Rs 500. Moreover, Himachal too has put a nightly curfew in Mandi, Shimla Kullu and Kangra, while Maharashtra has mandated negative COVID tests for travellers from Delhi, Rajasthan, Goa and Gujarat by air, trains, or road.
Updated 22:32 IST, November 23rd 2020